Skip to main content
Home
The Business History Conference

Main navigation

  • About
    • Mission & History
    • Governance and Bylaws
    • Contact Us
  • Meetings
    • All Annual Meetings
    • 2026 BHC Meeting
    • Midyear Meetings
    • Doctoral Colloquium
    • Emerging Scholars
    • Workshops
  • Prizes and Grants
    • Prizes & Grants
    • Prize Recipients
    • Prize Committees
  • News
    • H-BUSINESS
    • The Exchange Blog Archive
    • The Exchange Newsletter and Social Media
  • Resources
    • Calendar
    • Enterprise & Society
    • BEH Online
    • Expertise Database
    • Interest Groups
    • Teaching and Research Resources
    • Book series with BHC authors
    • Business history around the world
    • Twitterdex

Anonymous Login Menu

Oner Tulum

Senior Researcher, The Academic-Industry Research Network (theAIRnet), Research Affiliate, The William R. Rhodes Center for International Economics & Finance at the Watson Institute, Brown University
Twitter
pharmaceuticals, Innovation, Technology and Business, Technological Change, Management theory and history; Leadership; Science and technology studies; History of science; Marketing history; Consumer culture; Organizational Behavior;, Evolution of the Firm, historical methodology

Öner Tulum is a senior researcher at the Academic-Industry Research Network and an affiliate of The Rhodes Center for International Economics & Finance at the Watson Institute, Brown University. His current research on the pharmaceutical industry is being funded by grants from the Institute for New Economic Thinking and the Canadian Institute for Advanced Research. He held a post-doctoral fellowship at SOAS University of London, funded by the Gatsby Foundation, studying the UK pharma industry upon receiving his PhD from the University of Ljubljana with funding from the EU Horizon 2020 Research & Innovation Programme under the "Innovation-fuelled Sustainable, Inclusive Growth" project. Tulum’s pioneering research examines company-level activities related to strategy, organization, and finance that determine whether a business enterprise creates value through the generation of higher-quality/lower-cost products or, alternatively, enters into a “value extraction” mode of resource allocation through "financialization".



Recent Conference Participation
2026 BHC Meeting: Presenter, "The Tension between Innovation and Financialization in the U.S. Biopharmaceutical Industry: Merck, Sharp & Dohme Co."
2023 BHC Meeting: Presenter, "Money for Science or Science for Money? BioNTech and Moderna in the Development of the mRNA Covid-19 Vaccines"
2022 BHC Meeting : Presenter, "Transformation from Innovation to Financialization at Merck, Sharp & Dohme"

Copyright © The Business History Conference

Affiliated with: The AHA || H-NET || IEHA

Facebook LinkedIn Blue Sky  YouTube BHC Channel